Comparative Bioavailability of Risperidone.
Clinical trial NCT05179525 · COMPLETED
Trial details
- NCT number
- NCT05179525
- Sponsor
- Rovi Pharmaceuticals Laboratories
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-09
- Primary completion
- 2021-09-17
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.